Henry Schein Inc. (NASDAQ:HSIC) – Equities research analysts at William Blair cut their Q3 2016 earnings per share estimates for Henry Schein in a report released on Monday. William Blair analyst J. Kreger now expects that the firm will post earnings of $1.65 per share for the quarter, down from their prior estimate of $1.66. William Blair also issued estimates for Henry Schein’s FY2016 earnings at $6.56 EPS and FY2018 earnings at $7.97 EPS.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. During the same quarter in the previous year, the business posted $1.46 earnings per share. Henry Schein’s quarterly revenue was up 9.3% on a year-over-year basis.
HSIC has been the subject of several other reports. Zacks Investment Research downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Tuesday, September 20th. Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research note on Tuesday. Robert W. Baird reissued an “outperform” rating and issued a $176.00 price objective (up from $175.00) on shares of Henry Schein in a research note on Tuesday, October 4th. Finally, Bank of America Corp. began coverage on Henry Schein in a research note on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective for the company. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. Henry Schein presently has an average rating of “Buy” and an average target price of $160.50.
Shares of Henry Schein (NASDAQ:HSIC) opened at 158.45 on Wednesday. Henry Schein has a 12 month low of $140.11 and a 12 month high of $183.00. The company has a market cap of $12.96 billion, a PE ratio of 26.84 and a beta of 1.05. The company has a 50-day moving average of $162.49 and a 200 day moving average of $170.27.
In other news, Director Paul Brons sold 3,381 shares of the stock in a transaction on Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the transaction, the director now directly owns 13,715 shares in the company, valued at approximately $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.27% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in the company. Riverhead Capital Management LLC boosted its position in Henry Schein by 998.9% in the second quarter. Riverhead Capital Management LLC now owns 453,851 shares of the company’s stock worth $80,241,000 after buying an additional 412,549 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock worth $141,865,000 after buying an additional 286,976 shares in the last quarter. Janus Capital Management LLC boosted its position in Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock worth $358,522,000 after buying an additional 286,929 shares in the last quarter. Virginia Retirement Systems ET AL acquired a new position in Henry Schein during the second quarter worth $32,832,000. Finally, Bank of Montreal Can acquired a new position in Henry Schein during the second quarter worth $32,344,000. Institutional investors and hedge funds own 91.98% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.